There is growing body of evidence that GLP-1 RAs demonstrate numerous metabolic benefits in PCOS, including a high effect on prediabetes remission rate, a significant reduction in atherothrombotic markers, and an improvement in lipid profile (29–32). The gene discussed is GLP1R; the disease is polycystic ovary syndrome.